Article
Main Factors Predicting Nonresponders to Autologous Cell Therapy for Critical Limb Ischemia in Patients With Diabetic Foot.
Angiology - 1 Oct 2021
Dubský Michal, Fejfarová Vladimíra, Bem Robert, Jirkovská Alexandra, Nemcová Andrea, Sutoris Karol, Husáková Jitka, Skibová Jelena, Jude Edward B
Abstract excerpt
Autologous cell therapy (ACT) is a new treatment for patients with no-option critical limb ischemia (NO-CLI). We evaluated the factors involved in the nonresponse to ACT in patients with CLI and diabetic foot. Diabetic patients (n = 72) with NO-CLI treated using ACT in our foot clinic over a period of 8 years were divided into responders (n = 57) and nonresponders (n = 15). Nonresponder was defined as an...
Topics
Join the communities discussing this publication.